Simulations of measured photobleaching kinetics in human basal cell carcinomas suggest blood flow reductions during ALA-PDT

Lasers in Surgery and Medicine

Volumn 41, Issue 9, 2009, Pages 686-696

  Wang, Ken Kang Hsin ^a,e   Cottrell, William J ^b   Mitra, Soumya ^c   Oseroff, Allan R ^d   Foster, Thomas H ^a,b,c  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Fluorescence spectroscopy; Photodynamic therapy; Protoporphyrin IX; Skin cancer

Indexed keywords

AMINOLEVULINIC ACID; HEMOGLOBIN; NITRIC OXIDE; PROTOPORPHYRIN; PHOTOSENSITIZING AGENT;

ARTICLE; BASAL CELL CARCINOMA; BLEACHING; BLOOD FLOW VELOCITY; HUMAN; IRRADIATION; KINETICS; MATHEMATICAL MODEL; OXYGENATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SIMULATION; VASOCONSTRICTION; BIOLOGICAL MODEL; BLOOD FLOW; DRUG EFFECT; METABOLISM; PHOTOCHEMOTHERAPY; RADIATION EXPOSURE; SKIN TUMOR; SPECTROFLUOROMETRY; VASCULARIZATION;

AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; HUMANS; MODELS, CARDIOVASCULAR; PHOTOBLEACHING; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; REGIONAL BLOOD FLOW; SKIN NEOPLASMS; SPECTROMETRY, FLUORESCENCE;

EID: 70350442993     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20847     Document Type: Article

References (32)

1. Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 2004;5:497-508. (Pubitemid 39069400)
2. Grapengiesser S, Ericson M, Gudmundsson F, Larko O, Rosen A, Wennberg AM. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 2002;27:493-497. (Pubitemid 35278943)
3. Holmes MV, Dawe RS, Ferguson J, Ibbotson SH. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy. Br J Dermatol 2004;150:337-340. (Pubitemid 38352473)
4. Cottrell WJ, Paquette AD, Keymel KR, Foster TH, Oseroff AR. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer Res 2008;14:4475-4483.
5. Schacht V, Szeimies RM, Abels C. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application. Photochem Photobiol Sci 2006;5:452-458. (Pubitemid 43725965)
6. Herman MA, Fromm D, Kessel D. Tumor blood-flow changes following protoporphyrin IX-based photodynamic therapy in mice and humans. J Photochem Photobiol B 1999;52:99-104. (Pubitemid 30011501)
7. Enejder AM, af Klinteberg C, Wang I, Andersson-Engels S, Bendsoe N, Svanberg S, Svanberg K. Blood perfusion studies on basal cell carcinomas in conjunction with photodynamic therapy and cryotherapy employing laser-Doppler perfusion imaging. Acta Derm Venereol 2000;80:19-23.
8. Palsson S, Gustafsson L, Bendsoe N, Soto TM, Andersson-Engels S, Svanberg K. Kinetics of the superficial perfusion and temperature in connection with photodynamic therapy of basal cell carcinomas using esterified and non-esterified 5-aminolaevulinic acid. Br J Dermatol 2003;148:1179-1188. (Pubitemid 36819218)
9. Henderson BW, Waldow SM, Mang TS, Potter WR, Malone PB, Dougherty TJ. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 1985;45:572-576.
10. Fukumura D, Yuan F, Endo M, Jain RK. Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. Am J Pathol 1997;150:713-725. (Pubitemid 27073798)
11. Wang KK-H, Mitra S, Foster TH. A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy. Med Phys 2007;34:282-293 [Erratum: Med Phys 2008; 35: 4278-4280]. (Pubitemid 46035250)
12. Cottrell WJ, Oseroff AR, Foster TH. A portable instrument that integrates irradiation with fluorescence and reflectance spectroscopies during clinical photodynamic therapy of cutaneous disease. Rev Sci Instrum 2006;77:064302.
13. Cottrell WJ. Imaging, scattering, and spectroscopic systems for biomedical optics: Tools for bench top and clinical applications. Ph.D. Thesis. University of Rochester 2008, https://urresearch.rochester.edu/handle/1802/6288.
14. Hudson JA, Cater DB. An analysis of factors affecting tissue oxygen tension. Proc R Soc Lond B Biol Sci 1964;161:247-274.
15. Georgakoudi I, Nichols MG, Foster TH. The mechanism of photofrin photobleaching and its consequences for photodynamic dosimetry. Photochem Photobiol 1997;65:135-144. (Pubitemid 27084374)
16. Finlay JC. Reflectance and fluorescence spectroscopies in photodynamic therapy. Ph.D. Thesis. University of Rochester 2003, https://urresearch. rochester.edu/handle/1802/2805.
17. Dysart JS, Singh G, Patterson MS. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells. Photochem Photobiol 2005;81:196-205. (Pubitemid 40327580)
18. Robinson DJ, de Bruijn HS, van der Veen N, Stringer MR, Brown SB, Star WM. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: The effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol 1998;67:140-149.
19. Robinson DJ, de Bruijn HS, van der Veen N, Stringer MR, Brown SB, Star WM. Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin. Photochem Photobiol 1999;69:61-70.
20. Finlay JC, Conover DL, Hull EL, Foster TH. Porphyrin bleaching and PDT-induced spectral changes are irradiance dependent in ALA-sensitized normal rat skin in vivo. Photochem Photobiol 2001;73:54-63.
21. Foster TH, Murant RS, Bryant RG, Knox RS, Gibson SL, Hilf R. Oxygen-consumption and diffusion effects in photodynamic therapy. Radiat Res 1991;126:296-303.
22. Henning JP, Fournier RL, Hampton JA. A transient mathematical-model of oxygen depletion during photodynamic therapy. Radiat Res 1995;142:221-226.
23. Pogue BW, Hasan T. A theoretical study of light fractionation and dose-rate effects in photodynamic therapy. Radiat Res 1997;147:551-559. (Pubitemid 27204091)
24. Sheng C, Hoopes PJ, Hasan T, Pogue BW. Photobleaching-based dosimetry predicts deposited dose in ALA-PpIX PDT of rodent esophagus. Photochem Photobiol 2007;83:738-748. (Pubitemid 46854943)
25. Kruijt B, de Bruijn HS, van der Ploeg-van den Heuvel A, de Bruin RWF, Sterenborg HJCM, Amelink A, Robinson DJ. Monitoring ALA-induced PpIX-photodynamic therapy in the rat esophaugus using fluorescence and reflectance spectroscopy. Photochem Photobiol 2008;84:1515-1527.
26. Rengasamy A, Johns RA. Determination of Km for oxygen of nitric oxide synthase isoforms. J Pharmacol Exp Ther 1996; 276:30-33. (Pubitemid 26150949)
27. Gilissen MJ, van de Merbel-de Wit LE, Star WM, Koster JF, Sluiter W. Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas. Cancer Res 1993;53:2548-2552. (Pubitemid 23168021)
28. Jain RK. Determinants of tumor blood flow: A review. Cancer Res 1988;48:2641-2658. (Pubitemid 18137726)
29. Stucker M, Struk A, Altmeyer P, Herde M, Baumgartl H, Lubbers DW. The cutaneous uptake of atmospheric oxygen contributes significantly to the oxygen supply of human dermis and epidermis. J Physiol 2002;538:985-994. (Pubitemid 35190088)
30. Yu G, Durduran T, Zhou C, Wang HW, Putt ME, Saunders HM, Sehgal CM, Glatstein E, Yodh AG, Busch TM. Noninvasive monitoring of murine tumor blood flow during and after photodynamic therapy provides early assessment of therapeutic efficacy. Clin Cancer Res 2005;11:3543-3552. (Pubitemid 40627910)
31. Georgakoudi I, Foster TH. Singlet oxygen- versus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry. Photochem Photobiol 1998;67:612-625. (Pubitemid 128471939)
32. Star WM, Aalders MC, Sac A, Sterenborg HJ. Quantitative model calculation of the time-dependent protoporphyrin IX concentration in normal human epidermis after delivery of ALA by passive topical application or lontophoresis. Photochem Photobiol 2002;75:424-432.